Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Entellus Medical pays cash and stock for Spirox

Executive Summary

Entellus Medical Inc. is paying $25mm and issuing 3.4mm of its own shares (worth $50mm; $14.66 per share according to the merger agreement) to acquire private nasal device maker Spirox Inc. Spirox will also receive sales-based payments over a four-year period.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Stock
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash

Related Companies